| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |